US2023181792A1PendingUtilityA1

Methods of producing an osteoinductive calcium phosphate material for bone grafting

75
Assignee: SECADA MEDICAL LLC DBA VENTRIS MEDICAL LLCPriority: Mar 24, 2020Filed: Nov 21, 2022Published: Jun 15, 2023
Est. expiryMar 24, 2040(~13.7 yrs left)· nominal 20-yr term from priority
A61L 27/12A61L 2430/02A61L 27/3608A61L 27/54A61L 27/50A61L 2300/102A61L 27/3691A61L 2400/12A61L 2300/11A61L 27/3687
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods for producing biphasic calcium phosphate materials using chemical processing methods including exposure to peroxides. The resulting materials exhibit an osteoinductive needle-like surface morphology and are useful as artificial bone grafts.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for inducing bone tissue formation in a patient, the method comprising:
 providing granules for implantation in a patient, the granules comprising hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP), wherein the granules have been soaked in a solution comprising an oxidizing agent to produce one or more HA needle or nanorod protrusions from the granules’ surface.   
     
     
         2 . The method of  claim 1  wherein, prior to the soaking step, the granules have been hydrothermally treated. 
     
     
         3 . The method of  claim 2  wherein the hydrothermal treatment comprises autoclaving the granules at about 140° C. 
     
     
         4 . The method of  claim 3  wherein the granule has been autoclaved at about 140° C. for about 8 hours. 
     
     
         5 . The method of  claim 4  wherein the granules have been dried between autoclaving and soaking. 
     
     
         6 . The method of  claim 2  wherein the granules comprise about 60% HA and about 40% β-TCP. 
     
     
         7 . The method of  claim 6  wherein the oxidizing agent is hydrogen peroxide (H 2 O 2 ). 
     
     
         8 . The method of  claim 7  wherein the solution comprises about 50% H 2 O 2 . 
     
     
         9 . The method of  claim 8  wherein the granules have been soaked in a sealed container for about 6 hours. 
     
     
         10 . The method of  claim 2  wherein the hydrothermal treatment comprises autoclaving the granules at a temperature less than 125° C. 
     
     
         11 . The method of  claim 10  wherein the granules comprise about 20% HA and about 80% β-TCP. 
     
     
         12 . The method of  claim 11  wherein the peroxide is hydrogen peroxide (H 2 O 2 ). 
     
     
         13 . The method of  claim 12  wherein the solution comprises about 30% H 2 O 2 . 
     
     
         14 . The method of  claim 13  wherein the granules have been soaked in a sealed container for about 4 hours. 
     
     
         15 . The method of  claim 1  comprising providing the granules for implantation as a bone graft. 
     
     
         16 . The method of  claim 1  comprising providing the granules for implantation to promote wound healing. 
     
     
         17 . The method of  claim 1  comprising providing the granules for implantation in a maxillofacial procedure. 
     
     
         18 . The method of  claim 1  comprising providing the granules in a putty or paste format. 
     
     
         19 . The method of  claim 1  comprising providing the granules as a solid block of material. 
     
     
         20 . The method of  claim 19  comprising trimming the solid block of material to fit a bone defect in the patient.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.